FCCC LOGO Faculty Publications
Meropol NJ , Wong YN , Albrecht T , Manne S , Miller SM , Flamm AL , Benson AB 3rd , Buzaglo J , Collins M , Egleston B , Fleisher L , Katz M , Kinzy TG , Liu TM , Margevicius S , Miller DM , Poole D , Roach N , Ross E , Schluchter MD
Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical Trials
J Clin Oncol. 2016 Feb 10;34(5) :469-78
PMID: 26700123    PMCID: PMC4872012    URL: http://www.ncbi.nlm.nih.gov/pubmed/26700123
Back to previous list
PURPOSE: Lack of knowledge and negative attitudes have been identified as barriers to participation in clinical trials by patients with cancer. We developed Preparatory Education About Clinical Trials (PRE-ACT), a theory-guided, Web-based, interactive computer program, to deliver tailored video educational content to patients in an effort to overcome barriers to considering clinical trials as a treatment option. PATIENTS AND METHODS: A prospective, randomized clinical trial compared PRE-ACT with a control condition that provided general clinical trials information produced by the National Cancer Institute (NCI) in text format. One thousand two hundred fifty-five patients with cancer were randomly allocated before their initial visit with an oncologist to PRE-ACT (n = 623) or control (n = 632). PRE-ACT had three main components: assessment of clinical trials knowledge and attitudinal barriers, values assessment with clarification back to patients, and provision of a video library tailored to address each patient's barriers. Outcomes included knowledge and attitudes and preparation for decision making about clinical trials. RESULTS: Both PRE-ACT and control interventions improved knowledge and attitudes (all P < .001) compared with baseline. Patients randomly allocated to PRE-ACT showed a significantly greater increase in knowledge (P < .001) and a significantly greater decrease in attitudinal barriers (P < .001) than did their control (text-only) counterparts. Participants in both arms significantly increased their preparedness to consider clinical trials (P < .001), and there was a trend favoring the PRE-ACT group (P < .09). PRE-ACT was also associated with greater patient satisfaction than was NCI text alone. CONCLUSION: These data show that patient education before the first oncologist visit improves knowledge, attitudes, and preparation for decision making about clinical trials. Both text and tailored video were effective. The PRE-ACT interactive video program was more effective than NCI text in improving knowledge and reducing attitudinal barriers.
Meropol, Neal J Wong, Yu-Ning Albrecht, Terrance Manne, Sharon Miller, Suzanne M Flamm, Anne Lederman Benson, Al Bowen 3rd Buzaglo, Joanne Collins, Michael Egleston, Brian Fleisher, Linda Katz, Michael Kinzy, Tyler G Liu, Tasnuva M Margevicius, Seunghee Miller, Dawn M Poole, David Roach, Nancy Ross, Eric Schluchter, Mark D eng 2015/12/25 06:00 J Clin Oncol. 2016 Feb 10;34(5):469-78. doi: 10.1200/JCO.2015.63.2257. Epub 2015 Dec 23.